Skip to main content
. Author manuscript; available in PMC: 2020 Aug 3.
Published in final edited form as: J Neurooncol. 2011 Jun 28;105(3):607–612. doi: 10.1007/s11060-011-0628-z

Table 2.

Multivariate analysis including standard prognostic factors and the effect of any longitudinal increase in serum MMP-9 in glioblastoma patients

Variable Glioblastoma (n = 164, 140 deaths)
HR (95% CI) P

Each doubling in MMP-9 value 1.1 (0.9–1.2) 0.11
Age (per 10-year increase) 1.3 (1.1–1.5) 0.003
Extent of resection
 Gross total resection 1 0.02
 Partial resection 1.0 (0.7–1.5)
 Biopsy 1.8 (1.2–2.8)
Karnofsky performance scale
 <70 1 0.91
 ≥70 0.9 (0.4–2.1)